Kazuho Shimura
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.
Journal: British journal of haematology
Published: February 02, 2026
Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.
Journal: Leukemia & lymphoma
Published: March 26, 2025
Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine.
Journal: International journal of hematology
Published: February 11, 2024
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma.
Journal: International journal of hematology
Published: July 03, 2023
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti-SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms.
Journal: Infection and drug resistance
Published: November 09, 2022
Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.
Journal: Leukemia & lymphoma
Published: February 11, 2022
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study.
Journal: Cancer medicine
Published: January 18, 2022
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study.
Journal: International journal of hematology
Published: October 01, 2021
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 21, 2021
Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma.
Journal: Leukemia & lymphoma
Published: August 28, 2020
Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy.
Journal: International journal of hematology-oncology and stem cell research
Published: April 17, 2020
Corrosive injury of upper gastrointestinal tract by calcium oxide.
Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
Published: November 07, 2019
Last Updated: 09/26/2026